# Standard- and Micro-Dose rhBMP-2 for Implant Stability, Marginal Bone Loss, and Postoperative Sequelae: A Double-Blind Randomized Controlled Trial

> **NCT07696299** · NA · NOT_YET_RECRUITING · sponsor: **University of Baghdad** · enrollment: 60 (estimated)

## Conditions studied

- Tooth Loss / Rehabilitation
- Dental Implant
- Osseo-Integrated Implants

## Interventions

- **BIOLOGICAL:** Standard-dose rhBMP-2
- **BIOLOGICAL:** Micro-dose rhBMP-2
- **DRUG:** Sterile Normal Saline

## Key facts

- **NCT ID:** NCT07696299
- **Lead sponsor:** University of Baghdad
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12
- **Primary completion:** 2028-03
- **Final completion:** 2028-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07696299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07696299, "Standard- and Micro-Dose rhBMP-2 for Implant Stability, Marginal Bone Loss, and Postoperative Sequelae: A Double-Blind Randomized Controlled Trial". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07696299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*